Neurofibromatosis Type-1 Market Shares, Growth Factors, Revenue, Product Specifications, Segmentation
Neurofibromatosis is a genetic nervous system disorder. It primarily affects nerve cell growth. It is distinguished by the development of tumors on nerves. Neurofibromatosis is a hereditary disease that primarily affects children, but it can also occur as a result of gene mutation (change). Neurofibromatosis tumors are usually benign, but they can become cancerous at times. Neurofibromatosis is classified into three types: type 1 (NF1), type 2 (NF2), and Schwannomatosis. Symptoms vary between the three types. Neurofibromatosis is caused by a genetic mutation, which results in the development of tumors in various parts of the body, including nerve tissues, the brain, and the spinal cord. Neurofibromatosis type-1 market (NF1) is the most common of the three types of this disease. NF1 is a genetic disorder that affects one in every 2,000-2,500 people worldwide. It is most commonly diagnosed in early adulthood or childhood. Neurofibromatosis type-1 market is distingui...